Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 569-572

  Mogyorósi, András ^a,b   Lippman, Robert H ^a   Feldman, George M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Minimal change disease; Mycophenolate; Treatment

Indexed keywords

CYCLOSPORIN A; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; LISINOPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACNE; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

DRUG RESISTANCE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; NEPHROSIS, LIPOID; STEROIDS;

EID: 0036976869     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065276     Document Type: Article

References (16)

1. Adams PL, Iskandar SS, Rohr MS: Biopsyproven resolution of immune complex-mediated crescentic glomerulonephritis with mycophenolate mofetil therapy in an allograft. Am J Kidney Dis 1999;33:552-554.
2. Briggs WA, Choi MJ, Scheel PJ Jr: Follow-up on mycophenolate treatment of glomerular disease. Am J Kidney Dis 1998;31:898-899.
3. Briggs WA, Choi MJ, Scheel PJ Jr: Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 1998;31:213-217.
4. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 2000;343:1156-1162.
5. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G: Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int 1997;51:1583-1589.
6. Dooley MA, Cosio FG, Nachman PH, Falkenhain ME, Hogan SL, Falk RJ, Hebert LA: Mycophenolate mofetil therapy in lupus nephritis: Clinical observations. J Am Soc Nephrol 1999;10:833-839.
7. Glicklich D, Acharya A: Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis 1998;32:318-322.
8. Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M: Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 1999;14:58-63.
9. Jonsson CA, Svensson L, Carlsten H: Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice. Clin Exp Immunol 1999;116:534-541.
10. Kiberd B, MacDonald A: Mycophenolate and glomerular disease. Am J Kidney Dis 1998;31:364-365.
11. Miller G, Zimmerman R, III, Radhakrishnan J, Appel G: Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 2000;36:250-256.
12. Nowack R, Gobel U, Klooker P, Hergesell O, Andrassy K, van der Woude FJ: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999;10:1965-1971.
13. Penny MJ, Boyd RA, Hall BM: Mycophenolate mofetil prevents the induction of active Heymann nephritis: Association with Th2 cytokine inhibition. J Am Soc Nephrol 1998;9:2272-2282.
14. Van Bruggen MC, Walgreen B, Rijke TP, Berden JH: Attenuation of murine lupus nephritis by mycophenolate mofetil. J Am Soc Nephrol 1998;9:1407-1415.
15. Vanrenterghem Y: The use of mycophenolate mofetil (Cellcept) in renal transplantation. Contrib Nephrol. Basel, Karger, 1998, vol 124, pp 64-69.
16. Ziswiler R, Steinmann-Niggli K, Kappeler A, Daniel C, Marti HP: Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. J Am Soc Nephrol 1998;9:2055-2066.